GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » E10

Heron Therapeutics (STU:AXD2) E10 : €-2.69 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Heron Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.027. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.69 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -0.30% per year. During the past 5 years, the average E10 Growth Rate was 1.70% per year. During the past 10 years, the average E10 Growth Rate was 22.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Heron Therapeutics was 64.20% per year. The lowest was -90.10% per year. And the median was 14.80% per year.

As of today (2025-01-18), Heron Therapeutics's current stock price is €1.553. Heron Therapeutics's E10 for the quarter that ended in Sep. 2024 was €-2.69. Heron Therapeutics's Shiller PE Ratio of today is .


Heron Therapeutics E10 Historical Data

The historical data trend for Heron Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics E10 Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.02 -2.53 -2.99 -3.16 -2.93

Heron Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.91 -2.93 -2.86 -2.77 -2.69

Competitive Comparison of Heron Therapeutics's E10

For the Biotechnology subindustry, Heron Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heron Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Shiller PE Ratio falls into.



Heron Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Heron Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.027/133.0289*133.0289
=-0.027

Current CPI (Sep. 2024) = 133.0289.

Heron Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201412 -0.576 99.070 -0.773
201503 -0.647 99.621 -0.864
201506 -0.659 100.684 -0.871
201509 -0.561 100.392 -0.743
201512 -0.799 99.792 -1.065
201603 -0.826 100.470 -1.094
201606 -1.041 101.688 -1.362
201609 -1.105 101.861 -1.443
201612 -1.157 101.863 -1.511
201703 -0.935 102.862 -1.209
201706 -0.712 103.349 -0.916
201709 -0.646 104.136 -0.825
201712 -0.929 104.011 -1.188
201803 -0.657 105.290 -0.830
201806 -0.462 106.317 -0.578
201809 -0.420 106.507 -0.525
201812 -0.554 105.998 -0.695
201903 -0.708 107.251 -0.878
201906 -0.558 108.070 -0.687
201909 -0.381 108.329 -0.468
201912 -0.585 108.420 -0.718
202003 -0.516 108.902 -0.630
202006 -0.542 108.767 -0.663
202009 -0.543 109.815 -0.658
202012 -0.559 109.897 -0.677
202103 -0.487 111.754 -0.580
202106 -0.515 114.631 -0.598
202109 -0.434 115.734 -0.499
202112 -0.478 117.630 -0.541
202203 -0.572 121.301 -0.627
202206 -0.520 125.017 -0.553
202209 -0.384 125.227 -0.408
202212 -0.160 125.222 -0.170
202303 -0.252 127.348 -0.263
202306 -0.323 128.729 -0.334
202309 -0.159 129.860 -0.163
202312 -0.046 129.419 -0.047
202403 -0.018 131.776 -0.018
202406 -0.056 132.554 -0.056
202409 -0.027 133.029 -0.027

Add all the adjusted EPS together and divide 10 will get our e10.


Heron Therapeutics  (STU:AXD2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Heron Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Heron Therapeutics Business Description

Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Therapeutics Headlines

No Headlines